PADI2 and rheumatoid arthritis: This finding is in line with our prior observation that ACPAs from RA patients in aggregate do not preferentially target antigens citrullinated by one PAD over the other, but that individual patients can exhibit preferences for PAD2- or PAD4-citrullinated autoantigens, perhaps related to their particular disease etiology54.